Logistics & Transportation

Videos

Albert Thigpen, co-founder, Talentwise Consulting, shares how today’s consumer is empowered to make their own decisions as it relates to consumer choices in general, while outlining how the concept can be applicable to the healthcare and pharma industry.

Access Insights 2024: The Value of Retail Consumerism 

Articles

In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications. 

Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In

With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.

Rentschler Biopharma to Construct New Buffer Media Facility in Germany

Podcasts

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.  

The Impact of RFID: Enhancing Medication Management

The offering will become available in 49 states by next year. 

Walmart Introduces Same-Day Prescription Delivery Service

The partnership focuses on the expansion of real-time monitoring and other intelligence services.

 Sensitech, Qualcomm Form Cold Chain-Powered Collaboration 

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.

Access Insights 2024: Notable Breakout Sessions

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses examples of how effective communication can resolve supply chain issues. 

Effective Resolutions to Supply Chain Issues

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses how to handle opposing concerns between supply chain teams and offers communication solutions. 

LogiPharma USA 2024: Confronting Conflicting Priorities Between Supply Chain Partners

The now-11-year odyssey to track drugs by item through the supply chain will be under a regulatory exemption for up to two years.